Increased expression of vascular endothelial growth factor (VEGF) in Castleman's disease: Proposed pathomechanism of vascular proliferation in the affected lymph node

Leukemia and Lymphoma

Volumn 38, Issue 3-4, 2000, Pages 387-394

  Nishi, Jun Ichiro ^a   Maruyama, Ikuro ^a  

^a KAGOSHIMA UNIVERSITY   (Japan)

Author keywords

Castleman's disease; Human herpes virus 8; Lymph node; Plasma cell; Vascular endothelial growth factor; Vascular proliferation

Indexed keywords

CYCLOPHOSPHAMIDE; INTERLEUKIN 6; PREDNISOLONE; VASCULOTROPIN; VINCRISTINE;

ADOLESCENT; ADULT; ANGIOFOLLICULAR LYMPH NODE HYPERPLASIA; ARTICLE; BLOOD; CASE REPORT; CELL PROLIFERATION; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; HORMONE BLOOD LEVEL; HUMAN; HUMAN CELL; HUMAN HERPESVIRUS 8; HUMAN TISSUE; KAPOSI SARCOMA; MALE; PATHOGENESIS; PLASMA CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; SCHOOL CHILD;

EID: 0034122801     PISSN: 10428194     EISSN: None     Source Type: Journal    
DOI: 10.3109/10428190009087030     Document Type: Article

References (41)

1. Castleman, B., Iverson, L., and Menendez, V.P. (1956) Localized mediastinal lymphnode hyperplasia resembling thymoma. Cancer, 9, 822-830.
2. Keller, A.R., Hochholzer, L., and Castleman, B. (1472) Hyaline-vascular and plasma-cell types of giant lymph node hyperplasia of the mediastinum and other locations. Cancer. 29, 670-683.
3. Flendrig, J.A. (1970) Benign giant lymphoma: clinicopathologic correlation study. In The Year Book of cancer, edited by RL. Clark and RW. Cumley, pp. 296-299. Chicago. Year Book Medical Publishers.
4. Gaba, A.R., Stein, R.S., Sweet, D.L., and Vanakojis, D. (1978) Multicentric giant lymph node hyperplasia. American Journal of Clinical Pathology, 69: 86-90.
5. Weisenburger, D.D., Nathwani, B.N., Winberg, C.D., and Rappaport, H. (1985) Multicentric angiofollicular lymph node hyperplasia: a clinicopathologic study of 16 cases. Human Pathology, 16, 162-172.
6. Herrada, J., and Cabanillas, F.F. (1995) Multicentric Castleman's disease. American Journal of Clinical Oncology, 18, 180-183.
7. Gherardi, R.K., Malapert, D., and Degos, J.D. (1991) Castleman disease-POEMS syndrome overlap. Annals of Internal Medicine, 114, 520-521.
8. Adelman, H.M., Cacciatore, M.L., Pascual, J.F., Mike, J.M., Alberts, W.M. and Wallach, P.M. (1994) Case report: Castleman disease in association with POEMS. American Journal of the Medical Sciences. 307, 112-114.
9. Nakanishi, T., Sobue, I., Toyokura, Y., Nishitani, H., Kuroiwa, Y., Satoyoshi, E., Tsubaki, T., Igata, A., and Ozaki, Y. (1984) The Crow-Fukase syndrome: a study of 102 cases in Japan. Neurology. 34, 712-720.
10. Soubrier, M.J., Dubost, J.J., and Sauvezie, B.J. (1994) POEMS syndrome: a study of 25 cases and a review of the literature. American Journal of Medicine, 97, 543-553.
11. Gherardi, R.K., Belec, L., Fromont, G., Divine, M., Malapert, D., Gaulard, P., and Degos, J.D. (1994) Elevated levels of interleukin-1 beta (IL-1 beta) and IL-6 in serum and increased production of IL-1 beta mRNA in lymph nodes of patients with polyneuropathy, organomegaly, endocrinopathy, M protein, and skin changes (POEMS) syndrome. Blood, 83, 2587-2593.
12. Yoshizaki, K., Matsuda, T., Nishimoto, N., Kuritani, T., Taeho, L., Aozasa, K., Nakahata, T., Kawai, H., Tagoh, H., Komori, T., Kishimoto, S., Hirano, T., and Kishimoto, T. (1989) Pathogenic significance of interleukin-6 (IL-6/BSF-2) in Castleman's disease. Blood, 74, 1360-1367.
13. Winter, S.S., Howard, T.A., Ritchey, A.K., Keller, F.G., and Ware, R.E. (1996) Elevated levels of tumor necrosis factor-beta, gamma-interferon, and IL-6 mRNA in Castleman's disease. Medical and Pediatric Oncology, 26, 48-53.
14. Watanabe, O., Arimura, K., Kitajima, I., Osame, M., and Maruyama, I. (1996) Greatly raised vascular endothelial growth factor (VEGF) in POEMS syndrome. Lancet, 347, 702.
15. Soubrier, M., Dubost, J.J., Serre, A.F., Ristori, J.M., Sauvezie, B., Cathebras, P., Piette, J.C., Chapman, A., Authier, F.J., and Gherardi, R.K. (1997) Growth factors in POEMS syndrome: evidence for a marked increase in circulating vascular endothelial growth factor. Arthritis & Rheumatism. 40, 786-787.
16. Lesprit, P., Godeau, B., Authier, F.J., Soubrier, M., Zuber, M., Larroche, C., Viard, J.P., Wechsler, B., and Gherardi, R. (1998) Pulmonary hypertension in POEMS syndrome: a new feature mediated by cytokines. American Journal of Respiratory Critical Care Medicine. 157, 907-911.
17. Watanabe, O., Maruyama, I., Arimura, K., Kitajima, I., Arimura, H., Hanatani, M., Matsuo, K., Arisato, T., and Osame, M. (1998) Overproduction of vascular endothelial growth factor (VEGF/VPF) is causative in POEMS syndrome. Muscle & Nerve. 21, 1390-1397.
18. Foss, H.D., Araujo, I., Demel, G. Klotzbach, H., Hummel, M., and Stein, H. (1997) Expression of vascular endothelial growth factor in lymphomas and Castleman's disease. Journal of Pathology, 183, 44-50.
19. Nishi, J., Arimura K., Utsunomiya, A., Yonezawa, S., Kawakami, K., Maeno., N., Ijichi, O., Ikarimoto, N., Nakata, M., Kitajima, I., Fukushige, T., Takamatsu, H., Miyata, K., and Maruyama, I. (1999) Expression of vascular endothelial growth factor in sera and lymph nodes of the plasma cell type of Castleman's disease. British Journal of Haematology. 104, 482-5.
20. Maeno, N., Takei, S., Imanaka, H., Takasaki, I., Kitajima, I., Maruyama, I., Matsuo, K., and Miyata, K. Increased circulating vascular endothelial growth factor is correlated with disease activity in polyarticular juvenile rheumatoid arthritis. Journal of rhematology. (in press).
21. Hanatani, M., Tanaka, Y. Kondo, S., Ohmori, I., and Suzuki, H. (1995) Sensitive chemiluminescence enzyme immunoassay for vascular endothelial growth factor/vascular permeability factor in human serum. Bioscience Biotechnology and Biochemistry, 59: 1958-1959.
22. Keyt, B.A., Berleau, L.T., Nguyen, H.V., Chen, H., Heinsohn, H., Vandlen, R., and Ferrara, N. The carboxyl-terminal domain (111-165) of vascular endothelial growth factor is critical for its mitogenic potency. Journal of Biological Chemistry. 271, 7788-7795.
23. Soker, S., Takashima, S., Miao, H.Q., Neufeld G., and Klagsbrun, M. Neuropilin-1 is expressed by endothelial and tumor cells as an isoform-specific receptor for vascular endothelial growth factor. Cell. 92, 735-745.
24. Mandler, R.N., Kerrigan, D.P., Smart, J., Kuis, W., Villiger, P., and Lotz, M. (1992) Castleman's disease in POEMS syndrome with elevated interleukin-6. Cancer, 69, 2697-2703.
25. Ishiyama, T., Nakamura, S., Akimoto, Y., Koike, M., Tomoyasu, S., Tsuruoka, N., Murata, Y., Sato, T., Wakabayashi, Y., and Chiba, S. (1994) Immunodeficiency and IL-6 production by peripheral blood monocytes in multicentric Castleman's disease. British Journal of Haematology. 86, 483-489.
26. Cohen, T., Nahari, D., Cerem, L.W., Neufeld, G., and Levi, B.Z. (1996) Interleukin 6 induces the expression of vascular endothelial growth factor. Journal of Biological Chemistry, 271, 736-741.
27. Soulier, J., Grollet, L., Oksenhendler, E., Cacoub, P., Cazals-Hatem, D., Babinet, P., d'Agay, M.F., Clauvel, J.P., Raphael, M., Degos, L., and Francois, S. (1995) Kaposi's sarcoma-associated herpesvirus-like DNA sequences in multicentric Castleman's disease. Blood. 86, 1276-1280.
28. Chang, Y., Cesarman, E., Pessin, M.S., Lee, F., Culpepper, J., Knowles, D.M., and Moore, P.S. (1994) Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma. Science. 266: 1865-1869.
29. Ganem, D. (1997) KSHV and Kaposi's sarcoma: the end of the beginning? Cell. 91, 157-160.
30. Cesarman, E., Chang, Y., Moore, P.S., Said, J.W., and Knowles, D.M. Kaposi's sarcoma-associated herpesvirus-like DNA sequences in AIDS-related body-cavity-based lymphomas. (1995) New England Journal of Medicine. 332, 1186-1191.
31. Belec, L., Mohamed, A.S., Authier, F.J., Hallouin, M.C., Soe, A.M., Cotigny, S., Gaulard, P., and Gherardi, R.K. (1999) Human herpesvirus 8 infection in patients with POEMS syndrome-associated multicentric Castleman's disease. Blood. 93, 3643-3653.
32. Oksenhendler, E., Duarte, M., Soulier, J., Cacoub, P., Welker, Y., Cadranel, J., Cazals-Hatem, D., Autran, B., Clauvel, J.P., and Raphael, M. (1996) Multicentric Castleman's disease in HIV infection: a clinical and pathological study of 20 patients. AIDS. 10, 61-67.
33. Gessain, A., Sudaka, A., Briere, J., Fouchard, N., Nicola, M.A., Rio, B., Arborio, M., Troussard, X., Audouin, J., and Diebold, J. (1996) Kaposi sarcoma-associated herpes-like virus (human herpesvirus type 8) DNA sequences in multicentric Castleman's disease: is there any relevant association in non-human immunodeficiency virus-infected patients? Blood. 87, 414-416.
34. Barozzi, P., Luppi, M., Masini, L., Marasca, R., Savarino, M., Morselli, M., Ferrari, M.G., Bevini, M., Bonacorsi, G., and Torelli, G. (1996) Lymphotropic herpes virus (EBV, HHV-6, HHV-8) DNA sequences in HIV negative Castleman's disease. Journal of Clinical pathology. 49, M232-M235.
35. Kikuta, H., Itakura, O., Taneichi, K., and Kohno, M. (1997) Tropism of human herpesvirus 8 for peripheral blood lymphocytes in patients with Castleman's disease. British Journal of Haematology. 99, 790-793.
36. Moore, P.S., Boshoff, C., Weiss, R.A., and Chang, Y. (1996) Molecular mimicry of human cytokine and cytokine response pathway genes by KSHV. Science. 274, 1739-1744.
37. Parravicini, C., Corbellino, M., Paulli, M., Magrini, U., Lazzarino, M., Moore, P.S., and Chang, Y. (1997) Expression of a virus-derived cytokine. KSHV vIL-6, in HIV-seronegative Castleman's disease. American Journal of Pathology, 151, 1517-1522.
38. Aoki, Y., Jaffe, E.S., Chang, Y., Jones, K., Teruya-Feldstein, J., Moore, P.S., and Tosato, G. (1999) Angiogenesis and hematopoiesis induced by Kaposi's sarcoma-associated herpesvirus-encoded interleukin-6. Blood. 93, 4034-4043.
39. Bowne, W.B., Lewis, J.J., Filippa, D.A., Niesvizky, R. Brooks, A.D., Burt, M.E., and Brennan, M.F. (1999) The management of unicentric and multicentric Castleman's disease: a report of 16 cases and a review of the literature. Cancer. 85, 706-717.
40. Beck, J.T., Hsu, S.M., Wijdenes, J., Bataille, R., Klein, B., Vesole, D., Hayden, K., Jagannath, S., and Barlogie, B. (1994) Brief report: alleviation of systemic manifestations of Castleman's disease by monoclonal anti-interleukin-6 antibody. New England Journal of Medicine. 330, 602-605.
41. Tamayo, M., Gonzalez, C., Majado, M.J., Candel, R., and Ramos, J. Long-term complete remission after interferon treatment in a case of multicentric Castleman's disease. American Journal of Hematology. 49, 359-360.